The Lautenberg Act has passed both houses of Congress and is headed to the president's desk for signature. Here's why chemical investors don't need to worry.
After treading water for a failed acquisition attempt for much of 2015, Monsanto jumped after being courted by Bayer last month.
The company has a lot going for it, but its valuation is high compared with other manufacturers. Too high to invest?
Through a merger with Dow Chemical, followed by a three-way split, DuPont hopes to improve its fortunes. But the big beneficiary might not be DuPont's shareholders: it might be 3M's.
While the acquisition gives it greater penetration into retail markets, it is the global footprint that seems to be the real target market
LyondellBasell is a typical chemical company in some ways, but there are a couple of notable difference you'll want to watch closely.
Ashland is a company in transition. Here's a quick guide to what's going on.
Ashland is a company in transition, but when the changes are done, investors might re-evaluate the shares.
Shares of Dow are down 24.4% while shares of DuPont are down 26.8% since the announcement of their proposed merger in late 2015.
LydondellBasell is entering 2016 with a few risks that you should know about...